Научные публикации
Статьи, исследования и материалы, подготовленные специалистами научного центра «МираксБиоФарма».
-
3,3′-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models
-
Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
-
Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
-
Comparative preclinical pharmacokinetics study of 3,3?-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
-
RESEARCH ON PHARMACOKINETICS OF NEW FORMULIZATION OF DIINDOLYLMETHANE AT PATIENTS WITH HYPERPLASIA OF ENDOMETRIUM
-
SAFETY AND TOLERABILITY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA
-
PRELIMINARY RESULTS FROM A SAFETY AND TOLERABILITY STUDY OF THE PHARMACEUTICAL COMPOSITION BASED ON DIINDOLYLMETHANE IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA